224 related articles for article (PubMed ID: 20381110)
1. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.
Bentz GL; Liu R; Hahn AM; Shackelford J; Pagano JS
Virology; 2010 Jun; 402(1):121-8. PubMed ID: 20381110
[TBL] [Abstract][Full Text] [Related]
2. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
4. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC
J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.
Hahn AM; Huye LE; Ning S; Webster-Cyriaque J; Pagano JS
J Virol; 2005 Aug; 79(15):10040-52. PubMed ID: 16014964
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses.
Sen N; Sommer M; Che X; White K; Ruyechan WT; Arvin AM
J Virol; 2010 Sep; 84(18):9240-53. PubMed ID: 20631144
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
Liu X; Sadaoka T; Krogmann T; Cohen JI
J Virol; 2020 May; 94(11):. PubMed ID: 32213613
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
[TBL] [Abstract][Full Text] [Related]
9. Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.
Narulla MS; Alsairi A; Charmier L; Noonan S; Conroy D; Hall WW; Sheehy N
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768861
[TBL] [Abstract][Full Text] [Related]
10. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the IFN-α and -β Induction through Sequestering IRF7 into Viral Inclusion Bodies by Nonstructural Protein NSs in Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection.
Hong Y; Bai M; Qi X; Li C; Liang M; Li D; Cardona CJ; Xing Z
J Immunol; 2019 Feb; 202(3):841-856. PubMed ID: 30598516
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.
Darr CD; Mauser A; Kenney S
J Virol; 2001 Jul; 75(13):6135-42. PubMed ID: 11390615
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus LF2: an antagonist to type I interferon.
Wu L; Fossum E; Joo CH; Inn KS; Shin YC; Johannsen E; Hutt-Fletcher LM; Hass J; Jung JU
J Virol; 2009 Jan; 83(2):1140-6. PubMed ID: 18987133
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3.
Wang P; Deng Y; Guo Y; Xu Z; Li Y; Ou X; Xie L; Lu M; Zhong J; Li B; Hu L; Deng S; Peng T; Cai M; Li M
Front Immunol; 2020; 11():513383. PubMed ID: 33391252
[TBL] [Abstract][Full Text] [Related]
15. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
Ye J; Gradoville L; Miller G
J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250
[TBL] [Abstract][Full Text] [Related]
16. IRF7 Is Involved in Both STING and MAVS Mediating IFN-β Signaling in IRF3-Lacking Chickens.
Cheng Y; Zhu W; Ding C; Niu Q; Wang H; Yan Y; Sun J
J Immunol; 2019 Oct; 203(7):1930-1942. PubMed ID: 31366714
[TBL] [Abstract][Full Text] [Related]
17. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation.
Swenson JJ; Holley-Guthrie E; Kenney SC
J Virol; 2001 Jul; 75(13):6228-34. PubMed ID: 11390628
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.
Ning S; Huye LE; Pagano JS
J Biol Chem; 2005 Apr; 280(13):12262-70. PubMed ID: 15664995
[TBL] [Abstract][Full Text] [Related]
20. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]